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Abstract
The 2012 and 2013 annual influenza epidemics in Mexico were characterized by presenting
different seasonal patterns. In 2012 the A(H1N1)pdm09 virus caused a high incidence of
influenza infections after a two-year period of low circulation; whereas the 2013 epidemic
presented circulation of the A(H1N1)pdm09 virus throughout the year. We have character-
ized the molecular composition of the Hemagglutinin (HA) and Neuraminidase (NA) genes
of the A(H1N1)pdm09 virus from both epidemic seasons, emphasizing the genetic charac-
teristics of viruses isolated from Yucatan in Southern Mexico. The molecular analysis of
viruses from the 2012 revealed that all viruses from Mexico were predominantly grouped in
clade 7. Strikingly, the molecular characterization of viruses from 2013 revealed that viruses
circulating in Yucatan were genetically different to viruses from other regions of Mexico. In
fact, we identified the occurrence of two genetic variants containing relevant mutations at
both the HA and NA surface antigens. There was a difference on the temporal circulation
of each genetic variant, viruses containing the mutations HA-A141T / NA-N341S were
detected in May, June and July; whereas viruses containing the mutations HA-S162I / NA-
L206S circulated in August and September. We discuss the significance of these novel
genetic changes.
Introduction
Mexico and the United States of America were the first two countries to report the occurrence
of the novel A(H1N1)pdm09 virus in April 2009 [1, 2]. Since then and in the following years,
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the A(H1N1)pdm09 virus has been associated to annual epidemics and it is actually identified
as a seasonal virus together with influenza A(H3N2) and influenza type B virus.
The epidemiological characteristics of the influenza A(H1N1)pdm09 virus in Mexico has
been extensively described during different seasons, since the initial wave of the pandemic in
2009 to the further recurrence of the A(H1N1)pdm09 virus in season 2011–2012 and 2013–
2014 [3–6]. Likewise, some studies have specifically reported the epidemiology in different
geographic regions [7–9]. Under the same framework, the molecular characterization of the A
(H1N1)pdm09 virus is also a key component of the surveillance system worldwide. Conversely
to the epidemiological description, in Mexico, there exists an enormous gap of knowledge
about the molecular evolution of the influenza A(H1N1)pdm09 virus further after the initial
characterization at the time of the virus emergence [10, 11]. Differences in seasonal patterns of
circulation [3] as well as geographic differences between the 32 Mexican states may influence
the evolution of the A(H1N1)pdm09 virus as has been described in other regions of the world
[12–14]. The molecular characterization of the A(H1N1)pdm09 virus in Mexico has been lim-
ited to studies that analysed a reduced number of viral isolates from the influenza season
2011–2012 [15], or to studies that analysed clinical samples by deep sequencing to search for
viral markers of pathogenicity associated with severity and mortality [16, 17].
In the present study we describe the sequence analysis of hemagglutinin (HA) and neur-
aminidase (NA) from Mexican A(H1N1)pdm09 viruses submitted during 2012–2013 to the
public databases. The molecular analysis also included 98 HA and NA sequences of viruses iso-
lated in Yucatan during the recurrence of the A(H1N1)pdm09 virus in 2012 and the following
year 2013. The molecular characterization of all the sequences for the year 2013 identified the
presence of two genetic variants circulating exclusively in Yucatan. The phylogenetic analysis
clustered these variants as independent monophyletic groups, suggesting the occurrence of
natural events of genetic evolution. These results underline the need to close monitor the evo-
lution of the influenza virus through the molecular analysis in countries as vast as Mexico.
Materials and methods
Clinical material and viral isolation
Clinical material (throat swabs) was obtained from the repository of the Health Ministry
Regional Laboratory in Yucatan. Samples had been collected during the influenza season 2012
and 2013 as part of the sentinel surveillance system. Prior to storage at -70 ˚C, all samples were
confirmed as positive to the A(H1N1)pdm09 virus by real time RT-PCR following CDC proto-
col [18]. The Health Ministry Laboratory provided a list of all tested samples for each influenza
season (2012 and 2013). No epidemiological, demographic or personal data were proportioned
with the clinical sample, only the identification number (ID) assigned during reception.
Viral isolation was performed in Madin Darby Canine Kidney cells (MDCK). The MDCK
cells were seeded in 24-well plates and overnight incubated at 37 ˚C in a CO2 incubator
with 5% of CO2. An aliquot of each clinical sample (200 μl) was inoculated in duplicate and
completed to a final volume of 500 μl per well with 1X Dubelco´s Modified Eagles Media
(D-MEM- GIBCO) to avoid dryness during incubation. Plates were centrifuged at 2,500 rpm
during 1 hour at 25 ˚C, the viral inoculum was removed and cells were incubated with 1 ml of
1X D-MEM supplemented with TPCK- trypsin (SIGMA) at a final concentration of 2 μg/ml.
Infected cells were monitored daily until cytopathic effect (CPE) and monolayer destruction
was observed. Supernatant was harvested, centrifuged at 2,500 rpm/10 minutes to remove cell
debris, aliquot and stored at—70 ˚C until further use. Previous to storage, the presence of the
A(H1N1)pdm09 virus in the supernatant was detected by a conventional hemagglutination
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(HA) assay using a 1% suspension in PBS of turkey red blood cells, and confirmed by real time
RT-PCR.
Real-Time RT-PCR from viral isolates to confirm the A(H1N1)pdm09
virus
All viral isolates with an HA titre were confirmed as A(H1N1)pdm09 virus by real-time
RT-PCR according to CDC protocol [18]. The sequence of primers and FAM-labelled TaqMan
probes were actualized according to the InDRE protocol [19]. Previous to confirmation, viral
RNA was extracted by automated protocols using the MagnaPure LC 2.0 Instrument and the
MagnaPure LC total nucleic acid isolation kit protocol (Roche). The amplification procedure
was performed with SuperScript III RT/Platinum Taq Mix Kit (Invitrogen) under the follow-
ing reaction conditions, 5 μl of viral RNA, 1X Reaction Mix, 1 unit of RT/Platinum Taq
enzyme mix, 800 nM of each primer, 200 nM of TaqMan probe, and molecular grade water
for a final volume of 25 μl. A negative and a positive control were included for each run. The
amplification conditions were, for the RT step: 1 cycle at 50 ˚C for 15 min and 1 cycle at 95 ˚C
for 5 min; followed of 40 cycles at 95 ˚C for 15 sec and 1 min at 60 ˚C. All real-time RT-PCR
amplifications were performed using a StepOnePlus real-time PCR system (Applied Biosys-
tem), and data analysis using the OneStep Software V3.
RT-PCR amplification of HA and NA genes
HA and NA full gene amplification was performed by conventional RT-PCR according to
CDC protocol [20]. A set of ten or 8 primers (Table 1) were used to amplify five or four
overlapping fragments covering the complete HA and NA genes, respectively. Amplification
procedures were performed with the SuperScript One Step RT-PCR with platinum Taq kit
(Invitrogen) under the following reaction conditions: 1X of Mastermix, 400 nM of each
primer, 1 μl of the enzyme mix, 2 μL of viral RNA and molecular grade water to complete a
final volume of 25 μl. Amplification conditions for the RT step were 1 cycle at 50 ˚C for 30 min
Table 1. Sequence of primers used to amplify the full HA and NA genes of the influenza A(H1N1)pdm09 virus.
Target Fragment Primer sequence
HA 1 HA1F- TGTAAAACGACGGCCAGTATACGACTAGCAAAAGCAGGGG
HA461R- CAGGAAACAGCTATGACCTCATGATTGGGCCAYGA
2 HA351F- TGTAAAACGACGGCCAGTACRTGTTACCCWGGRGATTTCA
HA943R- CAGGAAACAGCTATGACCGAAAKGGGAGRCTGGTGTTTA
3 HA379F- TGTAAAACGACGGCCAGTACRTGTTACCCAGGRGATTTC
HA1204R- CAGGAAACAGCTATGACCTCTTTACCYACTRCTGTGAA
4 HA1124F- TGTAAAACGACGGCCAGTTGGATGGTAYGGTTAYCAYCA
HA1541R- CAGGAAACAGCTATGACCTCATAAGTYCCATTTYTGA
5 HA1204F- TGTAAAACGACGGCCAGTAAGATGAAYACRCARTTCACAG
HA1778R- CAGGAAACAGCTATGACCGTGTCAGTAGAAACAAGGGTGTTT
NA 1 NA0F- TGTAAAACGACGGCCAGTAGCAAAAGCAGGAGT
NA600R- CAGGAAACAGCTATGACCCTGGACCRGAAATTCC
2 NA536F- TGTAAAACGACGGCCAGTGGTCAGCAAGCGCATGYCATGA
NA1346R- CAGGAAACAGCTATGACCGCTGCTYCCRCTAGTCCAGAT
3 NA726F- TGTAAAACGACGGCCAGTAATGGRCARGCCTCRTACAA
NA1346R- CAGGAAACAGCTATGACCGCTGCTYCCRCTAGTCCAGAT
4 NA941F- TGTAAAACGACGGCCAGTTAGGATACATCTGCAGTGG
NA1452R- CAGGAAACAGCTATGACCAGTAGAAACAAGGAG
https://doi.org/10.1371/journal.pone.0189363.t001
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and 1 cycle at 94 ˚C for 2 min, followed of 30 cycles at 94 ˚C for 20 sec, 50˚C for 30 sec and 72
˚C for 1 min, with a final extension step at 72 ˚C for 7 min. All amplifications were performed
in a C-1000 Thermal cycler (BIO-RAD). PCR products were visualized in 1% TAE-Agarose
gels stained with Sybr Safe (Invitrogen).
Sanger sequencing of HA and NA genes
Prior to sequencing, all PCR products were purified using the enzyme EXOSAP-IT (Invitro-
gen); each mixture containing 4 μl of Exosap-it and 2 μl of PCR product was incubated at 37
˚C for 15 min followed of 80 ˚C during 15 min and immediately stored at 4 ˚C until use in the
sequencing reaction. The sequencing reaction was performed in a final volume of 20 μl using
the BigDye Terminator v1.1 Cycle sequencing kit (Applied Biosystems) under the following
conditions: 4 μl of buffer, 2 μl of BigDye, 3.2 μM of M13 primers [20] and 1 μl of purified PCR
product. Cycling conditions were as follow 1 cycle at 96 ˚C for 1 min and 25 cycles at 96 ˚C for
10 sec, 50 ˚C for 5 sec and 60 ˚C for 4 min. PCR products were purified using 96-well Centri-
Sep plates (Applied Biosystems) to remove excess of primers and labelled ddNTPs. Purified
products were concentrated and eluted in 20 μL of Hi-Di Formamide (Applied Biosystems),
heated at 95˚C for 5 min and immediately placed at 4 ˚C just before the run in a 310 genetic
analyzer (Applied Biosystem) using a performance optimized polimer-6 and a 310GA 61cm
x50 umid Capillary.
Phylogenetic analysis
Sequence analysis of 98 HA and NA full length genes from A(H1N1)pdm09 viruses isolated
from Yucatan during the 2012 and 2013 was performed with Geneious v6.0 (accession num-
bers are listed in S1 Table). All sequences were deposited at the GISAID influenza virus data-
base (http://platform.gisaid.org). Additionally, we retrieve 61-HA and 46-NA sequences from
Mexico (non-Yucatan) that were available from the two years of study; however, the sequence
and phylogenetic analysis was performed only with full-length sequences (35-HA and 22-NA).
The analysis also included 443-HA and 445-NA full length sequences from isolates collected
world-wide taking randomly sequences representative of all the continents deposited during
the two years of study. Sequences were retrieved from the GISAID and the NCBI public data-
base. Phylogenetic analysis was done with Mega v5. Independent phylogenetic trees for HA
and NA from each epidemic period were constructed using PHYML (maximum likelihood
phylogenies), the HKY85 (Hasegawa-Kishino-Yano, 85) model with a SH-like branch support.
All trees were constructed using the reference strain A/California/07/2009 as out-group.
Results
Temporal distribution of influenza A(H1N1)pdm09 virus during the period
2012 and 2013
Year 2012. The influenza season in Mexico had a recurrence of the A(H1N1)pdm09 virus
starting in early December 2011 and continued until April 2012 [6, 15, 21]. Interesting, the
recurrence of the A(H1N1)pdm09 virus arose after a previous season of undetectable levels of
circulation except for the particular outbreak in the Chihuahua state in March 2011, where
several associated deaths were reported [22]. From December 2011 to April 2012, the A
(H1N1)pdm09 virus was wide-spread in the Mexican territory mainly concentrated in the
central region, with low activity in the Southern states (S1 Fig). Particularly in Yucatan, the
presence of the virus was reported until January 2012, with the highest peak of detection in
February to decline in March (S2 Fig). According to the report from the Direccion General de
Influenza A(H1N1)pdm09 and genetic variants in Mexican viruses
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Epidemiologia (DGE), the recurrence of the A(H1N1)pdm09 virus caused at the national level
6,021 cases confirmed by laboratory and Yucatan contributed only with 1.2% (76 cases). Clini-
cal samples for viral isolation were selected according to the temporal occurrence in Yucatan.
For the year 2012 we selected a total of 48 clinical samples, viral isolation in MDCK cells was
achieved in 35 (73%) distributed during the three months of activity.
Year 2013. During the year 2013 the temporal distribution of the A(H1N1)pdm09 virus
in Mexico was clearly different to the previous season. Overall, the A(H1N1)pdm09 virus had
an extended season in Mexico starting from middle May 2013 until May 2014 [5, 23, 24]. The
A(H1N1)pdm09 virus was widely distributed in the Mexican territory with a highest rate of
detection than previous seasons; importantly the pattern of circulation showed a geographic
shift from the Southern to the Central/Northern states. From May to December 2013 Yucatan
contributed with a total of 144 confirmed cases (20% of positivity at national level). In particu-
lar according to the report by the Regional Laboratory, the A(H1N1)pdm09 virus was detected
in Yucatan as early in February throughout the year with the highest peak in the summer
months of June, July and August, at the same time that the influenza virus H3N2 (S2 Fig and
S3 Fig); a drop in virus detection occurred after September with sporadic cases the rest of the
year. To analyse the molecular evolution of the A(H1N1)pdm09 virus in Yucatan during this
year, viral isolates were recovered from a total of 45 (31%) clinical samples distributed from
May to October 2013.
Molecular characterization of the hemagglutinin and neuraminidase—
Season 2012
The molecular characterization of the A(H1N1)pdm09 virus for the year 2012 was performed
in a total of 21 HA and 16 NA full gene sequences from Yucatan. The complete sequence of
matching HA and NA genes was available in a total of 14 viruses (S1 Table). HA sequences
from Yucatan showed 99% of homology within them, 99% homology against the other Mexi-
can sequences analyzed in this study, and 98% homology compared to the reference strain A/
California/07/2009.
HA. The molecular characterization compared to the reference strain identify for the HA
a total of eleven amino acid changes (Table 2) detected in 95% of the sequences from Yucatan.
Amino acid changes S185T, S203T, S143G and A197T at the HA1 region placed viruses from
Yucatan at clade 7 in agreement with viruses isolated from Mexico (non-Yucatan) and around
the world [25]. Interestingly, mutation D97N that grouped viruses in clade 6 was absent in all
sequences available from Mexico and it was detected only in one sequence from Yucatan (A/
Yucatan/86/2012), besides it was already in circulation in 55% of sequences from other regions
of the world. Overall, all sequences from Mexico including viruses from Yucatan contain in
addition two mutations S69T and N260D [15] that were detected in only 43% of viruses ana-
lysed in this study mainly in viruses from North America. Amino acid changes at the antigenic
sites S185T and S203T were detected in all Mexican sequences.
The phylogenetic analysis of the HA sequences grouped together the Yucatan viruses char-
acterized by the presence of the mutation S69T, but separated from the other Mexican seq-
uences included in the study (S4 Fig). The single virus with the HA mutation D97N was
distant from the rest of the viruses in a single branch; it probably indicates the beginning of
circulation of clade 6 viruses in Yucatan. According to the phylogeny, there was a close rela-
tionship between all Mexican viruses analysed in this study along with viruses from North
America and Latin American countries. Noteworthy is the fact that the season 2012 in Mexico
was caused by viruses representing the clade 7 grouped in a big branch separated from 2012
viruses from clade 6 that were already in circulation.
Influenza A(H1N1)pdm09 and genetic variants in Mexican viruses
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NA. The molecular analysis of the NA gene in A(H1N1)pdm09 viruses from Yucatan
showed the presence of mutations N44S, V106I, V241I, N248D, and N369K commonly pres-
ent in virus from other regions of Mexico and the world (Table 3). In accordance with the
HA gene, all NA sequences from Mexico including Yucatan contained the mutation G41R
reported for viruses grouped in clade 7, although the frequency of detection in viruses from
other regions of the world was of 45%. The mutation H275Y associated to neuraminidase
inhibitors resistance was detected in 10 sequences from Mexico but none from Yucatan. The
percentage of similarity between the sequences from Yucatan and the reference strain was of
99% and within them of 100% identity.
The phylogenetic analysis of NA sequences from Yucatan and Mexico showed a similar
topology to the HA tree. Viruses from Yucatan grouped together but separated from viruses
from other regions of Mexico, and viruses with the resistance mutation also grouped in a sepa-
rate branch (S4 Fig). Viruses from Yucatan showed close relationship to viruses isolated from
South and Central America as well as North America, suggesting that A(H1N1)pdm09 viruses
circulating in Yucatan were probably introduced from these regions and not from viruses cir-
culating in central/north Mexico.
Table 2. Amino acid changes and frequency of occurrence in the hemagglutinin (HA) protein of the influenza A(H1N1)pdm09 viruses isolated in
Yucatan. Frequencies of detection for each mutation are also indicated for sequences from other regions of Mexico (non-Yucatan) and worldwide for the
period 2012–2013. Percentages were calculated based on the total number of sequences analysed in this study (n). Empty cells indicate values = 0.
Yucatan Mexico World
Mutation 2012 (n = 21) 2013
(n = 26)
2012 (n = 18) 2013
(n = 7)
2012
(n = 178)
2013 (n = 265)
S69T 100 3.8 100 43
P83S 100 96 94 100 97 100
D97N 4.8 96 100 55 91
I116M 4.8 38 14.3 <1 3
A141T 4.8 42 <1 2
S143G 100 100 53 8
S162I 46 14.3 1
K163Q 8 86 3 50
V173I 10 4 4
L174I 10
S185T 100 100 100 100 96 97
A197T 95 100 56 7
S203T 100 100 100 100 100 100
R205K 46 14.3 3 2
V234I 92 9 38
A256T 8 86 3 50
N260D 100 100 43
K283E 100 100 14 88
I321V 100 100 100 71 95 94
S359A 8
E47K* 100 92 100 100 100 99
S124N* 100 100 100 100 96 98
E172K* 92 100 22 94
V193A* 100 8 100 44 7
* Amino acid changes in HA2 region.
https://doi.org/10.1371/journal.pone.0189363.t002
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Genetic variants in viruses circulating in Yucatan during season 2013
The molecular characterization and phylogenetic analysis of the HA and NA sequences of viruses
from Yucatan for the period 2013 showed the occurrence of two genetic variants that circulated at
different times during the season. The percentage of homology within Yucatan sequences was of
99.8%, and compared to the reference strain A/California/7/2009 or the Mexican sequences from
other regions the percentage of homology was of 98.3 and 99.1% respectively.
HA. The molecular characterization was performed in 26 full HA sequences from Yucatan
and 7 from other regions of Mexico (available at the GISAID database). From all mutations
detected in the previous year 2012, only six were conserved (P83S, S185T, S203T, I321V,
E374K y S451N). The loss of mutations S143G and A197T and the occurrence of three new
mutations, D97N, V234I and K283E at the HA1 region, place all A(H1N1)pdm09 viruses from
Mexico including viruses from Yucatan in the predominant clade 6, subgroups 6B and/or 6C
[25]; these mutations were accompanied by E47K and E172K at the HA2 region (Table 1).
Interesting, we identified two mutations I116M and R205K at frequencies of 38% and 46%
respectively in viruses from Yucatan and detected in only one virus from Mexico (non-Yuca-
tan), and at very low frequencies of 3% in viruses from other regions of the world analysed in
our study. These results suggest that viruses from subtropical Yucatan possessed particular
genetic markers shared at very low frequencies with viruses globally in circulation.
The most significant finding in the A(H1N1)pdm09 viruses from Yucatan was the presence
of two mutations A141T and S162I with percentages of frequency of 42% and 46% (Table 1);
both mutations are localized at two antigenic sites at the HA globular head, Ca and Sa, respec-
tively (Fig 1). Mutation A141T was present in only 2% of worldwide sequences analysed in
this study with no presence in viruses from other regions of Mexico. Strikingly, mutation
S162I was unique for sequences from Yucatan; it was identified in only one sequence from
other regions of Mexico (A/Mexico/2733/2013) and in none of the sequences from other
regions of the world analysed in this study.
Table 3. Amino acid changes and frequency of detection in the Neuraminidase (NA) protein of the influenza A(H1N1)pdm09 virus isolated from
Yucatan, Mexico (non-Yucatan) and other regions of the world for the period 2012–2013. Percentages were calculated based on the total number of
sequences analysed in this study (n). Empty cells indicate values = 0.
Yucatan Mexico World
Mutation 2012
(n = 16)
2013 (n = 35) 2012 (n = 15) 2013
(n = 7)
2012
(n = 110)
2013
(n = 335)
I34V 6 86 46
G41R 100 100 45
N44S 100 100 100 100 74 95
V106I 100 100 73 5
N200S 86 26 94
L206S 29
V241I 100 100 100 100 100 98
N248D 100 100 100 100 100 99
I321V 31 86 5.5 48
N341S 31 <1
N369K 100 100 100 100 100 98
I393V 11
N397K 71 24
K432E 6 86 46
D451G 40 28.6 2.7 3
https://doi.org/10.1371/journal.pone.0189363.t003
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The phylogenetic analysis of the HA of viruses from the season 2013 clearly shows that
viruses from Yucatan are grouped into three different clades, a group of 12 viruses containing
the mutation S162I together with the virus from Mexico, a group of 11 viruses containing the
mutation A141T, and two viruses grouping close to the other Mexican strains (Fig 2); no
viruses containing both genetic changes were identified. Based on the classification by the
OMS [25], viruses from Mexico (non-Yucatan) are grouped in clade 6B containing mutations
D97N, K163Q, A256T and K283E. On the contrary, viruses from Yucatan are grouped in
clade 6C containing mutations D97N, V234I and K283E. Viruses A/Yucatan/374/2013 and A/
Yucatan/250/2013 were grouped in clade 6B along the other Mexican viruses; the virus A/
Yucatan/329/2013 was grouped in clade 6C without the genetic changes we have described.
The temporal distribution of the A(H1N1)pdm09 virus during the season 2013 showed an
extended period of circulation in Yucatan, with the highest frequency of circulation from June
until September. The mutation A141T was detected in June in 25% (4 out of 16) of the A
(H1N1)pdm09 viruses analysed, whereas the change S162I was detected in August (25%; 4 out
of 16) and September (21%; 3 out of 14); co-circulation of viruses containing one or another
genetic change occurred during the month of July (6 viruses with HA -A141T and 6 viruses
with HA -S162I) (S1 Table and Fig 3).
NA. The molecular analysis of the A(H1N1)pdm09 viruses isolated during the season
2013 was performed in a total of 35 full NA genes from Yucatan and compared with 7 NA
sequences from other regions of Mexico. Four mutations were conserved in all viruses from
Mexico and around the world, N44S, V241I, N248D and N369K (Table 3). The analysis
Fig 1. Schematic representation of the HA molecule of the A(H1N1)pdm09 virus. HA molecules were modelled using as template the crystal
structure of A 2009 H1N1 virus hemagglutinin from A/California/04/2009 (PDB 3LZG). Molecules were generated under flusurver structural model
database (http://flusurver.bii.a-star.edu.sg). Protein sequences were blast against A/California/07/2009 to identify differences on amino acid
composition. Right side HA molecule was modelled based on the strain A/Yucatan/116/2013 to indicate localization of the amino acid change
S162I (red oval). The HA molecule in the middle represents the amino acidic composition of the strain A/Yucatan/81/2013 indicating the position of
the mutation A141T (blue oval). Mutations at residues V234I, K283E and E499K (HA2) placed these viruses in clade 6C. Left side molecule
corresponds to the HA protein sequence of the strain A/Yucatan/18/2012.
https://doi.org/10.1371/journal.pone.0189363.g001
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Fig 2. Phylogenetic tree of HA nucleotide sequences of A(H1N1)pdm09 viruses from the year 2013. Twenty-six
HA sequences from Yucatan were aligned with 272 sequences from other regions of the world including seven from
Influenza A(H1N1)pdm09 and genetic variants in Mexican viruses
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identified viruses from Mexico (non-Yucatan) and worldwide still grouped in clade 6 and 7 by
containing mutation N200S and the revertants R41G and I106V [25]. Interesting none of the
viruses from Yucatan did acquire mutation N200S compared to sequences where the mutation
was identified in 86% and 94% in viruses from other regions of Mexico and the world respec-
tively. Another mutation that was absent in the Yucatan viruses was the N397K, which has been
reported mainly in North America and it was present in 71% of sequences from other regions
of Mexico analysed in this study. Moreover, we also identified four amino acid changes, L206S,
N341S, I393V and D451G at variable frequencies in the Yucatan viruses but either absent or
present in small numbers in viruses from other regions of Mexico and worldwide (Table 3).
Mutations L206S and N341S were exclusive of the Yucatan viruses, the former mutation was
identified in 8 NA sequences, whereas the last mutation was identified in 9 NA sequences and
two viruses A/Yucatan/102/2013 and A/Yucatan/138/2013 contained both amino acid changes
other regions of Mexico. Two independent clades were formed with sequences from Yucatan, corresponding to
viruses containing either A141T or S162I amino acid mutation.
https://doi.org/10.1371/journal.pone.0189363.g002
Fig 3. Temporal occurrence of genetic variants in Yucatan. Viruses from Yucatan with changes in HA and NA were distributed
in time from epidemiological week 23 to 38. The bars represent the total number of influenza cases reported by the Regional
Laboratory. The clear section indicates the number of confirmed cases of influenza A(H1N1)pdm09 and the grey section indicates
the number of influenza A(H1N1)pdm09 viruses with genetic changes in HA and NA (HA–A141T / HA–S162I / NA–N341S / NA–
L206S). The black section corresponds to the number of samples negative to influenza A(H1N1)pdm09 virus.
https://doi.org/10.1371/journal.pone.0189363.g003
Influenza A(H1N1)pdm09 and genetic variants in Mexican viruses
PLOS ONE | https://doi.org/10.1371/journal.pone.0189363 December 8, 2017 10 / 17
(Fig 4). The change I393V was identified in four NA sequences from Yucatan but was absent
from all other sequences from Mexico and worldwide analysed in this study; opposite, in 2012,
this mutation was identified in the NA sequences from Mexico (non-Yucatan) and the world,
but not in the Yucatan viruses. The last mutation of relevance was the amino acid change
D451G, which was found in a group of 14 sequences from Yucatan (40%), in one sequence
from other regions of Mexico and in only 3% of sequences from the world.
The phylogenetic analysis of the NA sequences from Yucatan clustered viruses in six differ-
ent groups according to the mutations we have previously described (Fig 4). The topology of
the NA tree is similar to the HA (Fig 2), where the Yucatan viruses grouped separate from the
viruses from other regions of Mexico. Two main clusters were formed, one for those viruses
containing the mutation L206S but proceeded by the mutation D451G at the node; and the
group of viruses containing the mutation N341S. These two mutations L206S and N341S in
NA were detected in the same group of viruses where the HA genetic changes A141T and
S162I were identified. A small subgroup within the D451G node was formed by viruses A/
Yucatan/97/2013, A/Yucatan/116/2013, A/Yucatan/152/2013 and A/Yucatan/260/2013 char-
acterized by lacking the mutation L206S, instead, they contained the mutation I321V which
was highly prevalent in viruses from Mexico (86%) and worldwide (48%). Additionally, a sec-
ond subgroup formed by viruses A/Yucatan/79/2013, A/Yucatan/123/2013, A/Yucatan/133/
2013 and A/Yucatan/150/2013 was characterized by the amino acid change I393V although
the N341S was absent within them. Finally, viruses A/Yucatan/250/2013 and A/Yucatan/374/
2013 were characterized by grouping with viruses from other regions of Mexico containing
mutations that were frequently detected worldwide (I34V and K432E); whereas viruses A/
Yucatan/329/2013 and A/Yucatan/345/2013 characterized by lacking all of the mutation previ-
ously describe (Fig 4).
The analysis of the temporal distribution showed that the genetic change N341S was
detected in 70% of A(H1N1)pdm09 viruses analysed in June (S1 Table). Then after, the genetic
change L206S was detected in 50% of the A(H1N1)pdm09 viruses analysed from August and
in 60% from September. The circulation of viruses with either genetic change was detected in
July (N341S in 50%; L206S in 28.5%). These results clearly indicate the presence in Yucatan of
a diverse pool of genetic variants of the influenza A(H1N1)pdm09 virus for the season 2013
(Fig 3).
Discussion
The influenza A(H1N1)pdm09 virus resurged in the Mexican territory during the season
December 2011- March 2012. The influenza season was characterized by a short period of cir-
culation but with a high incidence after two years of very low detection [6]. The molecular
characterization of a limited number of early isolates from the central region of the country
revealed the presence of three dominant amino acid changes with respect to the vaccine refer-
ence strain A/California/07/2009 [15]. Further during the same season the genetic analysis of a
larger number of HA and NA sequences including viruses from Subtropical Yucatan showed
high genetic similitude between all the sequences from Mexico. The amino acid differences,
S69T, S143G and N260D were detected in all the Mexican viruses analysed, and were also
detected in viruses from North America particularly from the regions of California and Texas
(S4 Fig). These amino acid changes seemed to represent a characteristic genetic marker of the
season 2011–2012 [26]. It is of particular interest the high incidence of the A(H1N1)pdm09
virus during the season 2011–2012, even though the vaccination campaign in Mexico started a
month before the peak of the season. Since the emergence in 2009, no immune scape variants
have been identified for the A(H1N1)pdm09 virus that could change the HA antigenic profile,
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thus the vaccine strain composition for the H1N1 subtype has been maintain for the last seven
years [27]. Therefore, the increased number of susceptible/naïve individuals after a long period
of low transmission could directly have an impact in the number of infected population in
2012.
The molecular analysis of viruses isolated during the 2013 allowed us to identify the occur-
rence of genetic variants with amino acid changes in 27% of influenza A(H1N1)pdm09 viruses
from Yucatan. Mutations detected in the HA -A141T and S162I- are located at the antigenic
sites Ca2 and Sa respectively, and they were recently reported in the H1N1pdm09 virus as B-
cell/Ab epitopes [28–30]. Influenza viruses can escape from the antibody-mediated neutraliza-
tion by accumulating mutations in HA in order to evade the protective immunity. However,
the evolution of the H1N1pdm09 virus has been remained antigenically homogeneous and
similar to the vaccine strain A/California/07/2009-like [31–33].
The amino acid A141T (A144T in H3 numbering) is located in the antigenic site Ca2. This
antigenic site together with Ca1 and Cb are considered induce cross-reactive protection. In H3
viruses this residue was associated with the emergency of escape mutants during the 1972/
1975 epidemics and the occurrence of antigenically different strains (A/Memphis/72 to A/Vic-
toria/75 [34, 35]. The relevance of this amino acid on (1) the antigenicity of the influenza
virus, (2) the emergence of escape variants and (3) the response to neutralization, has been
experimentally revealed in the presence of monoclonal antibodies against H3, H5 and recently
the pandemic H1 virus [29, 36, 37]. Globally, mutation A141T has been reported in viruses
from Canada with a frequency of detection of 30% in A(H1N1)pdm09 viruses isolated during
the 2012–2013 season [38]. A critical second finding in our study was the detection of muta-
tion N341S (N344S N2 numbering) in the NA of these viruses from Yucatan. This amino acid
is located at the antigenic site 4 of the N1NA subtype [39] in proximity to the catalytic site, and
has been implicated in the generation of antibody neutralization escape mutants in N2 and N8
viruses [40, 41].
The amino acid S162I (165 in H3 numbering) is located at the antigenic site Sa on the char-
acterized H1HA [28]. This antigenic site induces an antibody response strain-specific, and
very recently it has been described as experiencing “diversifying selection” [29]. Under this
context, the evolutionary analysis of the A(H1N1)pdm09 virus since its emergency, indicated
different events in this residue including the acquisition of a glycosylation site -S162N during
the epidemic period 2010–2011 [25]; actually highly prevalent in more than 80% of the viruses
circulating worldwide clustering viruses in a new sub-clade, the 6B.1 [42].
In this study we have described the emergence of genetic variants of influenza A(H1N1)
pdm09 viruses in a specific region of Mexico. Overall, this study underlines the need of contin-
uous monitoring of influenza viruses in different regions of Mexico with different seasonal
patterns as we have recently shown [43], and the need to increase the number of sequences
available to better characterize the influenza viruses circulating in larger countries as Mexico.
Supporting information
S1 Table. Accession number, virus name and date of collection of samples from Yucatan
for the period 2012 and 2013. Viruses from 2013 were coloured in red to indicate the pres-
ence of matching HA/NA mutations A141T+N431S or blue to indicate the paired mutation
S162I+L206S. Additionally, viruses with other mutations in NA were coloured in green for
Fig 4. Phylogenetic tree of NA sequences of the A(H1N1)pdm09 viruses for the period 2013.
Sequences from Yucatan are indicated in blue, from other regions of Mexico in red and worldwide in black.
Additional amino acid changes at the node are also indicated.
https://doi.org/10.1371/journal.pone.0189363.g004
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L206S+N341S; yellow I321V; pink I341V+K432E; or orange for viruses without any of the pre-
vious.
(XLSX)
S1 Fig. Map of Mexico showing geographic regions: South and South-east (Yucatan, Cam-
peche, Quintana Roo, Tabasco, Veracruz, Chiapas, Oaxaca, Guerrero); Central and Pacific
Central (Puebla, Morelos, Distrito Federal, Hidalgo, Guanajuato, Jalisco, Colima, Nayarit,
Aguascalientes, San Luis Potosı´, Zacatecas); North-east and North-west (Tamaulipas,
Nuevo Leo´n, Coahuila, Durango, Sinaloa, Chihuahua, Sonora, Baja California, Baja Cali-
fornia Sur).
(TIF)
S2 Fig. Temporal distribution of influenza A(H1N1)pdm09 viruses detected during season
2012 and 2013. The black solid line represents number of confirmed cases by laboratory in
Mexico including Yucatan (y axe). The dotted line represents number of confirmed cases by
the Regional laboratory in Yucatan (secondary y axe).
(TIF)
S3 Fig. Temporal circulation of influenza A and B in Yucatan during the 2013. Influenza
AH3N2 and A(H1N1)pdm09 were circulating at the same time from May until October. The
A(H1N1)pdm09 peaked in circulation from June to October whereas the H3N2 peaked from
July to October. At the end of the year, the influenza epidemic was predominated by influenza
B virus.
(TIF)
S4 Fig. Phylogenetic tree of HA and NA genes of influenza A(H1N1)pdm09 virus isolated
during 2012. Trees were constructed for HA and NA full-length nucleotide sequences from
different regions of the world. Viruses are coloured in black to represent worldwide strains,
red for viruses from Mexico (non-Yucatan), and blue for viruses specifically from Yucatan.
Trees were constructed using the PHYML method with a SH-like branch support.
(TIFF)
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